Antipsychotics for dementia raise ‘risk of serious harm’: Study From pneumonia to heart attacks, new research revealed the drugs do more harm than first thought, with the risks highest soon after initiation.
‘Breakthrough’ test for early dementia diagnosis a step closer Use of the blood test is expanding and local experts are excited about the impact it could have in Australia – should it become available.
Raising dementia awareness through collaboration GPs need to be better equipped with risk reduction tools and to help support patients with dementia, writes Dr Marita Long.
In Practice: RACGP Faculty elections commence Nominations are now being accepted and the college is calling on members to step up and help shape the future of general practice.
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Meta-analysis shows social interaction reduces dementia risk Strong social connections were associated with a lower risk of mild cognitive impairment, dementia and death.
Next steps for new Alzheimer’s treatment Approved this month in the US, Alzheimer’s disease treatment lecanemab is yet to undergo the regulatory approval process in Australia.
Does nose picking lead to dementia? Researchers Dr Joyce Siette and Professor Mark Patrick Taylor analyse a recent study that has generated a lot of media interest.
Controversial Alzheimer’s drug under TGA review ‘should not be approved’ Patients will be put at risk and taxpayers will face a significant economic burden if aducanumab receives regulatory approval, experts say.
Study links mental disorders early in life to dementia Mental health disorders are often an underappreciated category of modifiable risk factors for dementia, new research suggests.